{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:49:19Z","timestamp":1787881759494,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.canep.2019.101598","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T05:27:11Z","timestamp":1568698031000},"page":"101598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia"],"prefix":"10.1016","volume":"63","author":[{"given":"David","family":"Wyld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Youl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canep.2019.101598_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.beem.2007.01.004","article-title":"Tumour biology and histopathology of neuroendocrine tumours","volume":"21","author":"Kloppel","year":"2007","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.canep.2019.101598_bib0010","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0b013e3181ec124e","article-title":"The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems","volume":"39","author":"Klimstra","year":"2010","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.canep.2019.101598_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00535-014-0934-2","article-title":"Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis","volume":"50","author":"Ito","year":"2015","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.canep.2019.101598_bib0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7150\/jca.4502","article-title":"Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis","volume":"3","author":"Tsikitis","year":"2012","journal-title":"J. Cancer"},{"issue":"4","key":"10.1016\/j.canep.2019.101598_bib0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.canep.2019.101598_bib0030","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/cncr.23883","article-title":"Neuroendocrine tumor epidemiology: contrasting Norway and North America","volume":"113","author":"Hauso","year":"2008","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.canep.2019.101598_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062487","article-title":"The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study","volume":"8","author":"Tsai","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.canep.2019.101598_bib0040","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol."},{"issue":"7","key":"10.1016\/j.canep.2019.101598_bib0045","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1054\/bjoc.2000.1394","article-title":"Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974-97","volume":"83","author":"Levi","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.canep.2019.101598_bib0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/bjs.10034","article-title":"Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria","volume":"103","author":"Sandvik","year":"2016","journal-title":"Br. J. Surg."},{"issue":"6","key":"10.1016\/j.canep.2019.101598_bib0055","first-page":"931","article-title":"Epidemiology of neuroendocrine cancers in an Australian population","volume":"21","author":"Luke","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.canep.2019.101598_bib0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/PTS.0b013e3182948b1a","article-title":"Trends in computed tomography utilization rates: a longitudinal practice-based study","volume":"10","author":"Hess","year":"2014","journal-title":"J. Patient Saf."},{"issue":"2","key":"10.1016\/j.canep.2019.101598_bib0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/cncr.23159","article-title":"A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies","volume":"112","author":"Li","year":"2008","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.canep.2019.101598_bib0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4143\/crt.2012.44.3.157","article-title":"Gastrointestinal pathology study group of korean society of pathologists, current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000-2009: multicenter study","volume":"44","year":"2012","journal-title":"Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.canep.2019.101598_bib0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1743-7563.2011.01423.x","article-title":"Gastroenteropancreatic neuroendocrine tumors: incidence and treatment outcome in a single institution in Korea","volume":"7","author":"Lim","year":"2011","journal-title":"Asia. J. Clin. Oncol."},{"key":"10.1016\/j.canep.2019.101598_bib0080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1472-6823-12-30","article-title":"Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: a single-institution analysis (1995-2012) in South China","volume":"12","author":"Wang","year":"2012","journal-title":"BMC Endocr. Disord."},{"issue":"3","key":"10.1016\/j.canep.2019.101598_bib0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MCG.0b013e3181a9f10a","article-title":"Metastatic carcinoid tumor: changing patterns of care over two decades","volume":"44","author":"Townsend","year":"2010","journal-title":"J. Clin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.canep.2019.101598_bib0090","first-page":"369","article-title":"Pancreatic cancer epidemiology and survival in an Australian population","volume":"10","author":"Luke","year":"2009","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"8","key":"10.1016\/j.canep.2019.101598_bib0095","doi-asserted-by":"crossref","first-page":"511","DOI":"10.5694\/mja11.10890","article-title":"Pancreatic cancer: surgical management and outcomes after 6 years of follow-up","volume":"196","author":"Speer","year":"2012","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.canep.2019.101598_bib0100","unstructured":"StatsDirect, Survival Analysis. Available from https:\/\/www.statsdirect.com\/help\/survival_analysis\/cox_regression.htm. (Accessed 31 July 2019)."},{"issue":"2","key":"10.1016\/j.canep.2019.101598_bib0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000441897","article-title":"Changes in the epidemiology of neuroendocrine tumours","volume":"104","author":"Huguet","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.canep.2019.101598_bib0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/j.seminoncol.2018.07.001","article-title":"Epidemiologic trends in neuroendocrine tumors: an examination of incidence rates and survival of specific patient subgroups over the past 20 years","volume":"45","author":"Sackstein","year":"2018","journal-title":"Semin. Oncol."},{"issue":"1","key":"10.1016\/j.canep.2019.101598_bib0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.gie.2014.01.014","article-title":"Colonoscopy utilization and outcomes 2000 to 2011","volume":"80","author":"Lieberman","year":"2014","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.canep.2019.101598_bib0120","series-title":"Medicare Item Reports","author":"Medicare Australia","year":"2019"},{"key":"10.1016\/j.canep.2019.101598_bib0125","series-title":"National Bowel Cancer screening Program: Monitoring Report. Cancer series no. 104. Cat. No. CAN 103","author":"Australian Institute of Health and Welfare","year":"2017"},{"issue":"7","key":"10.1016\/j.canep.2019.101598_bib0130","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.healthpol.2017.04.010","article-title":"Increase in computed tomography in Australia driven mainly by practice change: a decomposition analysis","volume":"121","author":"Wright","year":"2017","journal-title":"Health Policy (New York)"},{"issue":"4","key":"10.1016\/j.canep.2019.101598_bib0135","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ijc.23529","article-title":"Risk factors associated with neuroendocrine tumors: a U.S.-Based case-control study","volume":"123","author":"Hassan","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.canep.2019.101598_bib0140","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00259-012-2123-y","article-title":"Comparison of (6)(8)Ga-DOTATATE and (6)(8)Ga-DOTANOC PET\/CT imaging in the same patient group with neuroendocrine tumours","volume":"39","author":"Kabasakal","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"3","key":"10.1016\/j.canep.2019.101598_bib0145","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/000313481207800344","article-title":"Increased risk of neoplasm in appendicitis treated with interval appendectomy: single-institution experience and literature review","volume":"78","author":"Carpenter","year":"2012","journal-title":"Am. Surg."},{"issue":"18","key":"10.1016\/j.canep.2019.101598_bib0150","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \"carcinoid\": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/j.canep.2019.101598_bib0155","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/cncr.29338","article-title":"Rural-urban disparities in incidence and outcomes of neuroendocrine tumors: a population-based analysis of 6271 cases","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.canep.2019.101598_bib0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000335018","article-title":"Treatment of gastroenteropancreatic neuroendocrine tumors with peptide receptor radionuclide therapy","volume":"97","author":"van Vliet","year":"2013","journal-title":"Neuroendocrinology"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782119301092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782119301092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:25:47Z","timestamp":1761801947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782119301092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":32,"alternative-id":["S1877782119301092"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2019.101598","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2019.101598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101598"}}